Modulation of T helper cell-mediated immune responses
US9156916B2 · kind B2 · utility
0Cited by
1References
5Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Apr 27, 2007 |
| Grant date | Oct 13, 2015 |
| Priority date | — |
| Expiry date | Jun 28, 2030 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Provided herein are methods for modulating one or more of a T-helper cell or monocyte lineage cell-mediated immune response in a subject, the method comprises administering to the subject an effective amount of a compound which binds to surface membrane immunoglobulin D (smIgD). Also provided are methods of diagnosis of one or more of a T-helper cell or monocyte lineage cell-mediated immune disease, and compositions and kits for use in such methods.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.